Amy Henrickson (Photo submitted by the University of Lethbridge)

By University of Lethbridge staff

U of L master’s student helps develop a better way to measure drug loading, enhance vaccine efficacy

Apr 10, 2021 | 7:45 AM

LETHBRIDGE, AB – In a recently published article in ACS Nano, a high-impact nanoscience and nanotechnology journal, University of Lethbridge master’s student Amy Henrickson (BSc ’17) and her collaborators at the University of British Columbia have devised a better way of measuring drug loading in lipid nanoparticle formulations (LNPs) using analytical ultracentrifugation (AUC).

These formulations are typically used in gene therapies and, more recently, in the development of some COVID vaccines. Lipid nanoparticles are very small and can be thought of as a capsule for delivering a treatment. Lipids occur naturally in the body in the form of fats, hormones and certain vitamins. In the case of the COVID vaccines, lipid nanoparticles are loaded with RNA that instructs the human body to recognize the spike proteins on the SARS-CoV-2 virus and thus build immunity.

For the quality control of these formulations, researchers need an accurate way of determining the RNA loading state of LNP formulations, because only a narrow range of RNA loading leads to the desired biological effect and assures patient safety; empty or overloaded LNPs are ineffective and can increase the potential for allergic reactions.

“The new method we developed is able to tell us the ratio of RNA to lipid,” says Henrickson, who studies under biophysicist Dr. Borries Demeler, a Canada 150 Research Chair. “There are advantages and disadvantages to all techniques, but many other methods involve low resolution bulk observations that lack the necessary detail. This method is able to tell if any LNPs are empty and if everything’s properly loaded with the preparation.”

The method, developed over the past two years at the Canadian Center for Hydrodynamics at the U of L, uses multi-wavelength AUC to measure the spectral profile of nanoparticle preparations, quantifying the RNA contained in the LNP. They also use heavy water to measure densities of preparations, which is sensitive to the RNA load. The work was done in collaboration with Pieter Cullis’ group at UBC, where they are working on developing lipid nanoparticles for gene therapy.

Nighttime construction on Hwy 3 in Lethbridge starts April 17

Apr 17, 2025

SASHA launches #BuyABed fundraiser to support vulnerable Lethbridge residents

Apr 04, 2025

$20K grants available: TELUS STORYHIVE Pan-Asian Edition opens applications April 1

Mar 18, 2025

“In her short time as a graduate student in the Department of Chemistry & Biochemistry, Amy has already amassed 10 publications, including first-author contributions like the ACS Nano publication,” says Demeler. “Amy is a star student who has helped our group make significant and high-impact progress in many important fields, contributing novel discoveries to gene therapy and vaccine development.”